HIV i-Base report from the 6th Joint Conference of the British HIV Association (BHIVA) and the British Association for Sexual Health and HIV (BASHH)
Researchers from Queen Mary University of London and the Share Collaborative presented results from a study on HIV and neurodivergence that was part of a large survey focused on injectable ART.
The research was coproduced with European community advocates, and although the study’s specific focus was the use of injectable CAB/RPV-LA and was funded by ViiV, it also produced an interesting dataset on people living with HIV who have autism or ADHD.
This was an online anonymous survey distributed through social media and community networks in 18 European countries and available in 18 languages including Arabic, Russian, Turkish and Ukrainian.
Read the full report here.
Source : HIV i-Base
Related HIV and Co-Infections News
-
New York University: Marker of biological aging linked to some but not all symptoms of depression
-
Infectious Disease Advisor: Switching ART regimens common in virologically suppressed HIV
-
[Press release] FDA grants priority review of New Drug Application for Gilead’s once-daily HIV treatment of bictegravir plus lenacapavir
Get involved
Are you living with HIV/AIDS? Are you part of a community affected by HIV/AIDS and co-infections? Do you work or volunteer in the field? Are you motivated by our cause and interested to support our work?
Subscribe
Stay in the loop and get all the important EATG updates in your inbox with the EATG newsletter. The HIV & co-infections bulletin is your source of handpicked news from the field arriving regularly to your inbox.